Skip to main content

Table 1 Demographic characteristics of study subjects

From: The effectiveness and pharmacoeconomic study of using different corticosteroids in the treatment of hypersensitivity pneumonitis

Parameter

Betamethasone (N = 35)

Dexamethasone (N = 33)

Prednisolone

(N = 39)

P-Value*

 

Age (years) (mean ± SD)

45.94 ± 12.11

45.21 ± 9.93

46.62 ± 11.84

0.873Θ

 

Weight (Kg) (mean ± SD)

78.39 ± 19.66

79.21 ± 15.58

78.95 ± 20.22

0.987Θ

 

Height (cm) (mean ± SD)

158.46 ± 8.97

160.17 ± 6.31

158.36 ± 8.04

0.647Θ

 

Disease Duration (years) (mean ± SD)

3.87 ± 2.53

4 ± 3.39

4.24 ± 5.04

0.928Θ

 

Gender (No. of Females (%))

33 (94.29%)

27 (81.8%)

35 (89.74%)

0.258â—Š

 

BMI (No. > 30 Kg/m2(%))

17 (48.57%)

19 (57.6%)

22 (56.41%)

0.714â—Š

 

No. of Subjects with Smoking History (%)

3 (8.57%)

2 (6.1%)

3 (7.7%)

0.922â—Š

 

No. of Hypertensive Subjects (%)

7 (20%)

5 (15.2%)

6 (15.38%)

0.829â—Š

 

No. of Diabetic Subjects (%)

6 (17.14%)

4 (12.1%)

9 (23.1%)

0.477â—Š

 

Number of patients with other comorbidities (%)

  

Pulmonary hypertension (%)

3 (8.6%)

2 (6.1%)

3 (7.7%)

0.072â—Š

 

Cardiac problems (%)

1 (2.86%)

1 (3.03%)

4 (10.26%)

  

Cancer (%)

2 (5.7%)

 

1 (2.56%)

  

Rheumatoid arthritis (%)

2 (5.7%)

    

Hepatosplenomegaly (%)

2 (5.7%)

    

Others (%)

2 (5.7%)

 

2 (5.13%)

  
  1. SD: Standard Deviation
  2. BMI: body mass index
  3. No.: Number
  4. * Level of Significance at p < 0.05
  5. Θ One way ANOVA Test
  6. â—Š Chi-Square Test